These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 12663588)

  • 1. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
    Rodríguez-Morán M; Guerrero-Romero F
    Diabetes Care; 2003 Apr; 26(4):1147-52. PubMed ID: 12663588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.
    Guerrero-Romero F; Tamez-Perez HE; González-González G; Salinas-Martínez AM; Montes-Villarreal J; Treviño-Ortiz JH; Rodríguez-Morán M
    Diabetes Metab; 2004 Jun; 30(3):253-8. PubMed ID: 15223977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial.
    Rodríguez-Moran M; Guerrero-Romero F
    Arch Med Res; 2014 Jul; 45(5):388-93. PubMed ID: 24830937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial.
    Mooren FC; Krüger K; Völker K; Golf SW; Wadepuhl M; Kraus A
    Diabetes Obes Metab; 2011 Mar; 13(3):281-4. PubMed ID: 21205110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.
    Simental-Mendía LE; Rodríguez-Morán M; Guerrero-Romero F
    Arch Med Res; 2014 May; 45(4):325-30. PubMed ID: 24814039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
    Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
    Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2011 Apr; 41(4):405-10. PubMed ID: 21241290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
    Guerrero-Romero F; Rodríguez-Morán M
    J Hum Hypertens; 2009 Apr; 23(4):245-51. PubMed ID: 19020533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.
    Toprak O; Kurt H; Sarı Y; Şarkış C; Us H; Kırık A
    Kidney Blood Press Res; 2017; 42(1):33-42. PubMed ID: 28297698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
    Drenthen LCA; de Baaij JHF; Rodwell L; van Herwaarden AE; Tack CJ; de Galan BE
    Diabetologia; 2024 Jan; 67(1):52-61. PubMed ID: 37922013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Razzaghi R; Pidar F; Momen-Heravi M; Bahmani F; Akbari H; Asemi Z
    Biol Trace Elem Res; 2018 Feb; 181(2):207-215. PubMed ID: 28540570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial.
    Ranasinghe P; Wathurapatha WS; Galappatthy P; Katulanda P; Jayawardena R; Constantine GR
    J Diabetes; 2018 May; 10(5):386-397. PubMed ID: 29072815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia.
    Navarrete-Cortes A; Ble-Castillo JL; Guerrero-Romero F; Cordova-Uscanga R; Juárez-Rojop IE; Aguilar-Mariscal H; Tovilla-Zarate CA; Lopez-Guevara Mdel R
    Magnes Res; 2014; 27(2):48-56. PubMed ID: 25204013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral magnesium supplementation on selected cardiovascular risk factors in non-insulin-dependent diabetics.
    Purvis JR; Cummings DM; Landsman P; Carroll R; Barakat H; Bray J; Whitley C; Horner RD
    Arch Fam Med; 1994 Jun; 3(6):503-8. PubMed ID: 8081529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial.
    Guerrero-Romero F; Simental-Mendía LE; Hernández-Ronquillo G; Rodriguez-Morán M
    Diabetes Metab; 2015 Jun; 41(3):202-7. PubMed ID: 25937055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
    Song Y; He K; Levitan EB; Manson JE; Liu S
    Diabet Med; 2006 Oct; 23(10):1050-6. PubMed ID: 16978367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.
    Sadeghian M; Azadbakht L; Khalili N; Mortazavi M; Esmaillzadeh A
    Biol Trace Elem Res; 2020 Jan; 193(1):23-35. PubMed ID: 30835085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.